Cadient Group, a leading online pharmaceutical marketing firm, today announced the appointment of Stephen Wray as President and Chief Executive Officer. Mr. Wray, a seasoned pharmaceutical marketing executive, replaces interim CEO Christopher J. French, who now assumes the position of Chairman of Cadient’s Board of Directors. The announcement marks the culmination of a nationwide search begun early this year.
